By I. Glenn Cohen First, and unrelated to this post, I wanted to say that like everyone here in Boston (and it seems throughout the U.S.) my heart goes out to the folks injured by Monday’s blast and their friends and family. Now on to the substance. I have participated in a number of Supreme…
By John Robertson Glenn Cohen and Eli Adashi have an interesting Sounding Board piece in the latest NEJM[i] on made-to-order embryos for sale. A California clinic offering this option has garnered enormous publicity. It might, however, have stimulated more bioethical thinking than actual demand for its services. On the bioethical side, Glenn and Eli survey the…
By I. Glenn Cohen The New England Journal of Medicine just published a new article by me (and my frequent co-author Dean Eli Adashi) entitled “Made-to-Order Embryos for Sale — A Brave New World?” As we note in the article: The proliferation of commercial gamete sources (e.g., sperm and oocyte banks) has opened the door…
By Kimberly Mutcherson On Friday, April 5, a group of almost 30 (mostly legal) scholars gathered at Rutgers Law-Camden to have difficult conversations about abortion and assisted reproduction. The event, sponsored by Rutgers Law and the Law School Initiative of the Center for Reproductive Rights (https://reproductiverights.org/en/our-work/law-school-initiative) sought to initiate discussion about the seeming gulf between…
By I. Glenn Cohen I have a new peer-commentary paper in the American Journal of Bioethics, entitled “Of Modest Proposals and Non-Identity: A Comment on the Right to Know Your Genetic Parents.” This is a response to An Ravelingien and Guido Pennings’s very interesting article “The Right to Know Your Genetic Parents: From Open-Identity Gamete…
By I. Glenn Cohen Rebecca Skloot, author of the very interesting and well-written bestseller The Immortal Life of Henrietta Lacks — a book about the poor and badly treated black woman whose cells became the famous (and very heavily used) HeLa cells, medicine and the treatment of African-Americans, and who owns products derived from one’s…
By Arthur Caplan Last week, the American College of Medical Genetics and Genomics issued new recommendations on disclosure of incidental findings in clinical exome and genome sequencing. Take a listen to Art Caplan‘s response over at The Takeaway.
By Dov Fox Glenn Cohen and I make the case in this morning’s Huffington Post: This week the United Kingdom joined the ranks of countries like Canada, Israel, and Sweden that provide in vitro fertilization (IVF) treatment to citizens under a certain age (42 in the U.K.) who can’t have children without it. That includes gays and lesbians. When it comes to…
By Adriana Benedict Today, Professor Glenn Cohen announced on this blog that he, in conjunction with two others, filed an amicus brief in AMP v. USPTO (Myriad), a case concerning Myriad’s patents on isolated DNA and cDNA. In a paper I have been writing on the natural phenomenon doctrine as applied to biotechnology patents, I…
